Table 1. Clinicopathologic features of vulvar cancers.
Sample | Age (years) | Tumor size in diameter (cm) | Diagnosis | Extent of carcinoma | HPV infection (high- and low-risk types) | Sample source |
---|---|---|---|---|---|---|
VSCC1 | 60 | 3.5 | Vulva SCC | Microinvasion | + (HPV16, −) | FFPE |
VSCC2 | 74 | 3 | Vulva SCC | invasion (7.0 mm) | + (HPV16, −) | Frozen |
VSCC3 | 78 | 3 | Vulva SCC | Invasion (8.0 mm) | + (HPV58, −) | FFPE |
VSCC4 | 61 | 0.5 | Vulva SCC | Microinvasion | + (HPV16, −) | FFPE |
VSCC5 | 66 | 2 | Vulva SCC | Invasion (6.0 mm) | + (HPV52, −) | FFPE |
VSCC6 | 47 | 1.5 | Vulva SCC | Invasion (1.0 mm) | + (HPV16, −) | FFPE |
VSCC7 | 70 | 2.5 | Vulva SCC | Invasion (7.0 mm) | — | FFPE |
VSCC8 | 70 | 4 | Vulva SCC | Invasion (4.0 mm) | — | FFPE |
VSCC9 | 45 | 1.3 | Vulva SCC (VIN) | No invasion | — | FFPE |
VSCC10 | 61 | 0.6 | Vulva SCC | Invasion (1.4 mm) | — | FFPE |
VSCC11 | 62 | 2.4 | Vulva SCC | Invasion (1.0 mm) | — | FFPE |
VSCC12 | 69 | 4 | Vulva SCC | Invasion (7.0 mm) | — | FFPE |
VSCC13 | 79 | 4 | Vulva SCC | Invasion (1.0 mm) | — | FFPE |
VSCC14 | 64 | 1.7 | Vulva (VIN) SCC | No invasion | — | FFPE |
VSCC15 | 83 | 1.2 | Vulva SCC | Invasion (4.0 mm) | — | FFPE |
Abbreviations: FFPE, formalin-fixed paraffin-embedded; HPV, human papilloma virus; VIN, vulva intraepithelial neoplasm.
HPV infection risk types are indicated in parentheses (high risk, low risk).
High-risk HPVs are indicated by the numbers 16, 52, and 58.